
Bajaj Finserv Healthcare Fund - Direct Plan - Growth
Bajaj Finserv Mutual Fund · Sectoral/Thematic · Direct · Growth
NAV · as of 11/09/2026
12.26
1D
-0.21%1Y
+22.14%Key stats
- Expense ratio
- 0.88%
- AUM
- ₹376.70 Cr
- Launched
- 27/12/2024
- Fund manager
- Siddharth Chaudhary; Vinay Bafna; Bharat Hegde
- Portfolio turnover
- 0.41%
- Risk
- Very High Risk
- Min lump-sum
- ₹500
- Min SIP
- ₹500/mo
- Fresh lump-sum
- Accepted
- Fresh SIP
- Accepted
NAV history
Bajaj Finserv Healthcare Fund - Direct Plan - Growth
13/08/2026 to 11/09/2026
O - H - L -
Top holdings
39 disclosed- 1.9.67%
Divi's Laboratories Ltd
Healthcare
- 2.8.87%
Sun Pharmaceuticals Industries Ltd
Healthcare
- 3.6.60%
Piramal Pharma Ltd
Healthcare
- 4.6.50%
Apollo Hospitals Enterprise Ltd
Healthcare
- 5.6.13%
Aurobindo Pharma Ltd
Healthcare
- 6.6.01%
Rubicon Research Ltd
Healthcare
- 7.5.48%
Torrent Pharmaceuticals Ltd
Healthcare
- 8.4.42%
Neuland Laboratories Ltd
Healthcare
- 9.4.37%
Emcure Pharmaceuticals Ltd
Healthcare
- 10.3.80%
Max Healthcare Institute Ltd Ordinary Shares
Healthcare
- 11.3.01%
Fortis Healthcare Ltd
Healthcare
- 12.2.66%
Zydus Wellness Ltd
Consumer Defensive
- 13.2.41%
Laurus Labs Ltd
Healthcare
- 14.2.34%
Ipca Laboratories Ltd
Healthcare
- 15.2.20%
Vijaya Diagnostic Centre Ltd
Healthcare
- 16.2.11%
Senores Pharmaceuticals Ltd
Healthcare
- 17.2.02%
Shaily Engineering Plastics Ltd
Basic Materials
- 18.2.01%
Navin Fluorine International Ltd
Basic Materials
- 19.1.78%
Dr. Lal PathLabs Ltd
Healthcare
- 20.1.70%
Sanofi Consumer Healthcare India Ltd
Healthcare
- 21.1.68%
GlaxoSmithKline Pharmaceuticals Ltd
Healthcare
- 22.1.64%
Glenmark Pharmaceuticals Ltd
Healthcare
- 23.1.39%
Bajaj Money Market Dir Gr
- 24.1.37%
Dr Reddy's Laboratories Ltd
Healthcare
- 25.1.33%
Zydus Lifesciences Ltd
Healthcare
- 26.1.29%
Biocon Ltd
Healthcare
- 27.1.15%
Clearing Corporation Of India Ltd
- 28.1.07%
Krishna Institute of Medical Sciences Ltd
Healthcare
- 29.0.96%
Medi Assist Healthcare Services Ltd
Healthcare
- 30.0.95%
OneSource Specialty Pharma Ltd
Healthcare
- 31.0.87%
Jubilant Pharmova Ltd
Healthcare
- 32.0.86%
Net Receivables / (Payables)
- 33.0.83%
Turtlemint Fintech Solutions Ltd
Financial Services
- 34.0.27%
Sumitomo Chemical India Ltd Ordinary Shares
Basic Materials
- 35.0.23%
MTAR Technologies Ltd
Industrials
- 36.-
AstraZeneca Pharma India Ltd
- 37.-
Abbott India Ltd
- 38.-
Medplus Health Services Ltd
- 39.-
Eris Lifesciences Ltd Registered Shs
Sector allocation
- Healthcare88.58%
- Basic Materials4.30%
- Unclassified3.41%
- Consumer Defensive2.66%
- Financial Services0.83%
- Industrials0.23%
Comparable peers
Bajaj Finserv Healthcare Growth Direct Plan
Bajaj Finserv Healthcare (G) · ₹376.70 Cr AUM
1Y+23.21%3Y0.00%-SBI Healthcare Opportunities Growth Direct Plan
SBI Healthcare Opportunities (G) · ₹5.80 K Cr AUM
1Y+22.13%3Y+24.61%-Mirae Asset Healthcare Growth Direct Plan
Mirae Healthcare (G) · ₹3.44 K Cr AUM
1Y+20.35%3Y+23.20%-UTI Healthcare Growth Direct Plan
UTI Healthcare (G) · ₹1.44 K Cr AUM
1Y+17.28%3Y+24.42%-HDFC Transportation & Logistics Growth Direct Plan
HDFC Transportation & Logistics (G) · ₹1.96 K Cr AUM
1Y+9.79%3Y+25.46%-
Investment objective
The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
Scheme details
- Scheme code
- 153157
- Fund house
- Bajaj Finserv Mutual Fund
- Category
- Open Ended
- Type
- Equity Scheme
- Sub-category
- Sectoral/Thematic
- Plan
- Direct
- Return type
- Growth
- ISIN (Growth)
- INF0QA701AB9
- ISIN (Div. Reinvest)
- -
- Tradable on exchange
- No